Janssen Announces FDA Approval of SYMTUZA
The Janssen Pharmaceutical Companies of Johnson & Johnson announced on July 18, 2018 that the U.S. FDA has approved the use of SYMTUZA, the...
Gut Instinct
AIDS Healthcare Foundation Trains a Research Lens on Probiotics
by Chael Needle
"Probiotics” has become a new buzz word in the dairy aisle—at least two brands...
The Road Ahead
LifeGuide
Treatment Horizons
The Road Ahead
New candidates hold promise for ARV therapy & therapeutic vaccines
by Mariel Selbovitz, MPH
The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...
HPV Immunotherapy Research
Warts & All
An immunotherapy candidate seeks to address complications from HPV
by Chael Needle
Human papillomavirus (HPV) is the most common sexually transmitted infection, but, according...
Barriers to Treatment Use
LifeGuide
Opening Doors
A new survey uncovers barriers to treatment
by Chael Needle
There’s an old chestnut that goes something like this: People won’t make a change...
Editing Genes for a Cure
Close to the Edit
A functional cure candidate modifies genes to create HIV-resistant cells
by Chael Needle
Gary Blick, MD, AAHIVS, Medical & Research Director of CIRCLE...
HIV Latency & HDACs
Hide and Seek
Led by Dr. Daria Hazuda, researchers tackle HIV latency with HDAC inhibitors
by Chael Needle
With all the talk around viral suppression, it may...
TANGO Study Starts
In February 2018, ViiV Healthcare announced the start of a forty-eight-week phase III study designed to determine whether adults with HIV-1 who have achieved...
First Line
A treatment for advanced HIV-associated Kaposi’s sarcoma is relaunched
by Chael Needle
Newly acquired by Galen from Gilead Sciences, DaunoXome (daunorubicin citrate liposome injection) is an...
New Nukes, Old Nukes
Nuclear Waste
How to get overwhelmed by the data on new nukes, old nukes & lots of
different classes of ART at AIDS 2014
by Mariel...
LATEST POSTS
Ron B: Cover Story
“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...
